The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Somnath Chatterjee
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Somnath Chatterjee, Promoter, Chairman & Joint Managing Director of Suraksha Diagnostic Ltd, has purchased 8,200 equity shares (0.016% of the company's equity) through an open market purchase on 14 August 2025. His total holding has risen from 26,38,768 shares (5.067%) to 26,46,968 shares (5.082%) of the company's paid-up equity capital of 5,20,80,758 shares. The acquisition was made in his personal capacity as a promoter and disclosed to BSE and NSE under Regulation 29(2) of the SEBI Takeover Regulations. No encumbrance (pledge/lien) is involved in this transaction.
This is a small open-market purchase by the promoter, indicating confidence in the company. The increase in promoter holding is marginal (0.016%), so this is likely a routine personal investment move rather than a strategic stake change.